Skip to main content

Latest collections open to submissions

NEW: Diet and physical activity during and after cancer treatment

Guest Edited by Nicolas H. Hart and Dominic O’Connor

NEW: Immunology and immunotherapy in solid cancers

Guest Edited by Zachary C. Hartman and Daniel Smrz

Editors' Picks

New Content ItemAn exploratory study of cell stiffness as a mechanical label-free biomarker across multiple musculoskeletal sarcoma cells


New Content ItemSmall molecule targeting of the p38/Mk2 stress signaling pathways to improve cancer treatment


New Content ItemCancer survivorship challenges of rural older adults: a qualitative study

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last month!

Articles

Targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions

Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions

Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020

Cross journal collection: Precision Oncology
Collection published: 28 August 2019

Browse all BMC Cancer collection contributions


Aims and Scope


BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here

Breast Cancer Awareness Month

July - Sarcoma Awareness Month

Breast Cancer Awareness Month runs for the whole of October. We hope you will enjoy reading the following study protocol recently published in BMC Cancer that will investigate the feasibility of generating patient-derived tumor organoids from triple negative breast cancers and their ability to predict clinical response. 

New Content ItemThe TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer

Become an Editorial Board Member

We are recruiting new Editorial Board Members.

Read More

New Content Item (1)

BMC Cancer is celebrating its 20th anniversary! 

Since launching in 2001, we've become established as the largest open access oncology journal in our field. We're proud of our history of making cancer research and methods available to all. We have been looking back at our achievements and highlighted some of the most influential research published in the journal over the past two decades. 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • 2022 Citation Impact
    3.8 - 2-year Impact Factor
    4.3 - 5-year Impact Factor
    1.166 - SNIP (Source Normalized Impact per Paper)
    1.137 - SJR (SCImago Journal Rank)

    2022 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    148 days submission to accept (Median)

    2022 Usage 
    7,665,706 downloads
    11,097 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal